In the ER with dad, I went to the bathroom and a code was called, I have never prayed so hard not to hear the number 82
Narjust Florez, MD, FASCO
@narjustflorezmd.bsky.social
Assc. Director CCEP & Thoracic Oncologist @DanaFarberNews & @Harvardmed| Young Lung Cancer | Editor @Jamaonc | Co-founder @LatinasInMed | @Florez_Lab
From @hsph.harvard.edu on Instagram. In FY 25, 46% of the school's budget came from federal grants. Thinking of the many friends I have at Harvard Chan right now who just want to do work that will make the world healthier.
Honored to receive this recognition by Leaders in Healthcare as the 2025 Rising Star Woman in Healthcare. Gracias Totales!
✨ It’s so shiny we can’t stop staring or taking📸👀🌟 @narjustflorezmd.bsky.social Rising Star Women Leader in Healthcare Award just arrived and it’s giving serious disco ball energy 💃🏽💫 (just like her plant hehe✨)
Tom Lynch (@fredhutch.bsky.social) and Skip Burris (@scri.com) on how NIH funding cuts imperil biopharma innovation—and cost patient lives. In a time of uncertainty, “react to the knowns, not the fear” https://cancerletter.com/podcastc/20250516_1/
The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives In a time of uncertainty, “react to the knowns, not the fear”...
Thomas J. Lynch Jr. and Howard A. “Skip” Burris III lead two institutions that couldn’t be more different—an NCI-designated Comprehensive Cancer Center on one side of the country and a for-profit research enterprise on the other—but they stay up at nights worrying about the same thing: “Changing the paradigm of how research is funded and […]
cancerletter.com
Humans are built resilient and some decide to use their struggles to excel Each time I visit “La Casa Azul” - Frida Kahlo’s house, I am reminded that I can find joy during the dark days & dare to be my true self
Women have unique challenges when facing a #LungCancer diagnosis. Drs. Narjust Florez and Isabel Preeshagul will address them during our May 14 Together Separately livestream, Women and Lung Cancer. Join us at 4 pm ET - sign up at LCRF.org/together. #WomenLC @narjustflorezmd.bsky.social
Together Separately: Women and Lung Cancer - Lung Cancer Research Foundation
Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and thoracic medical oncologist at Dana-Farber Brigham Cancer Center, will join us once again for our popular Women and […]
lcrf.org
On #LungCancerConsidered this week, @narjustflorezmd.bsky.social & Dr. Mihaela Aldea talk about RET-positive NSCLC: diagnostic hurdles, treatment choices & more! 🎧 Tune in: bit.ly/TL25RET #TexasLung25 #NSCLC
What You Should Know About RET-Positive NSCLC: Live from TexasLung25 | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about th ...
bit.ly
Dr @narjustflorezmd.bsky.social doesn’t shy away from tough, taboo topics. @lungevity.bsky.social #HopeSummit, she led a powerful convo on how cancer affects identity, relationships, intimacy & sexual health. Her message: you deserve care, pleasure & to feel whole. Great party favours #LCSM
Dra. @narjustflorezmd.bsky.social D es la líder que necesitamos en la Junta Directiva de la IASLC. Visionaria. Inclusiva. Valiente. ¿Necesitas más razones para votar por la Dra. Flórez? ✔️ Tiene una visión clara ✔️ Toma acción ✔️ Tiene un historial de impacto
🎙 Together, Separately: Lung Cancer & Women Join @narjustflorezmd.bsky.social & Dr. Preeshagul in an important conversation on lung cancer and women’s health. 🗓 May 14 🕓 4 PM – 5:00 PM (ET) 📍 Don’t miss this powerful dialogue on disparities, advocacy, and change. #HearHer lcrf.org/together
Together Separately: Women and Lung Cancer - Lung Cancer Research Foundation
Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and thoracic medical oncologist at Dana-Farber Brigham Cancer Center, will join us once again for our popular Women and […]
lcrf.org
Years after @ascocancer.bsky.social adopted respectful language guidelines, a study shows noncompliance is widespread. Speaking with @oncologynews.bsky.social, coauthor @narjustflorezmd.bsky.social @danafarber.bsky.social continues pushing for change in how patients are spoken about. bit.ly/3EQoBF5
ASCO Abstracts Show Persistent Noncompliance With Language of Respect Guidelines
Although ASCO adopted guidelines on using language of respect for patients and professionals in 2020, a recent study found that compliance is still sorely lacking.
bit.ly
📢 That’s why we’re voting for Dr. @narjustflorezmd.bsky.social a trailblazer in research, mentorship, and global equity in cancer care. 📅 Don’t miss your chance to make an impact. 📩 Check your email for a ballot from noreply@directvote.net 🗓️ Deadline to vote: May 22
New article alert!!!! @healthcentral.bsky.social Making Cancer Clinical Trials Work for Everyone, featuring commentary from @narjustflorezmd.bsky.social
#AACR25 kicks off today and we’re proud to highlight exciting #headandneck, #breastcancer, #lungcancer and #cancersurvivorship research studies presented by @danafarber.bsky.social faculty. Check out the highlights here: bit.ly/4jLGH9Q
From discussing young lung ca to the increasing incidence in women, the last 24 hrs in Cali, Colombia were full exchange of ideas Desde discusiones sobre el ca de pulmón en jóvenes hasta el aumento de casos en mujeres, las últimas 24 hrs en Cali, Colombia estuvieron llenas de intercambio de ideas
Two great days in Medellin full of discussion about ALK + lung cancer and new friendships and collaborations. Dos días en Medellín llenos de discusiones sobre el cancer de pulmón ALK + y nuevas amistades y colaboraciones. Como decía Cerati - Gracias Totales!!
As I reflect in the future, I realized the hard work and love we have put into the @IASLC podcast We extended our reach by introducing episodes in new languages Brought to stage early investigators from many regions Added discussions about sexual health, financial toxicity & more
Live at #TexasLung25, @narjustflorezmd.bsky.social hosts Drs. Eric Singhi & Misty Shields on a new episode of #LungCancerConsidered for a talk on patient education & communication in oncology. 🎧 Listen now: bit.ly/TL25LCC #TexasLung25 #patientadvocacy #oncology
Excuse me, What? Top Recommendations for Effective Patient Communication in Oncology: Live from TexasLung25 | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Eric Singhi and Dr. Mi ...
bit.ly
✅ Vote FLOREZ! Dr @narjustflorezmd.bsky.social Is running for the @iaslc.bsky.social Board of Directors. Her entire career has been dedicated to: 👉 Improving outcomes for people with #lungCancer 👉 Innovative research & ideas 👉 Strong mentorship to the next gen in #lcsm 🗳️ Undesignated Group # 4
Our own @danafarber.bsky.social Dr. @NarjustFlorezMD is running for @iaslc.bsky.social Board. Let us support NJ! @narjustflorezmd.bsky.social @danafarbernews.bsky.social
From podcast host (since 2021) to 2024 WCLC Chair, it has been my honor to work with @IASLC to improve current practices, integrate new voices and bring patients to the forefront. And will continue with the same mission Election is open!
Thank you! Your trust means so much! Undesignated seat #4
Thank you friend - the sister that @ascocancer.bsky.social gifted me more than 10 years ago. Across a poster hall, I found a life-long friend. Please vote!
Fumiko Ladd Chino, MD FASCO@fumikochino.bsky.social · last yr.✅ Vote FLOREZ! Dr @narjustflorezmd.bsky.social Is running for the @iaslc.bsky.social Board of Directors. Her entire career has been dedicated to: 👉 Improving outcomes for people with #lungCancer 👉 Innovative research & ideas 👉 Strong mentorship to the next gen in #lcsm 🗳️ Undesignated Group # 4
Asking for your support as we try to make a difference TOGETHER!
Story time about our EQUAL study - Reasons why we developed the largest @Florez_Lab study to date! If interested in participating and you are in New England - email us at equalstudy@dfci.harvard.edu
On the new episode of #LungCancerConsidered @narjustflorezmd.bsky.social & Dr. Corey Langer discuss major updates from #ELCC25. These updates include MARIPOSA and ORCHARD & SOHO-01 trials, plus strategies to address treatment toxicity. 🎧 Listen here: bit.ly/LCC25ELCC #ELCC25
ELCC 2025: Insights and Review of the Data | IASLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez and Dr. Corey Langer discuss data presented at the recent European Lung Cancer Congress (ELCC ...
bit.ly
I am gonna get real with y’all Wedding planning is fun and everything Until … They ask you what type of white you want?!? Like - how many types are they?
Who qualifies for the EQUAL study? - early diagnosis of EGFR positive lung cancer You can reach us to equalstudy@dfci.harvard.edu